Acasti Pharma Inc. (ACST) Buy Target – $2.25 or better

Trade Setup

Buy Target – $2.25 or better
Sell Target – TradersPro Sell Signal

Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patients with hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada.

 
Trending Ideas

Featured Stocks On The Move